# Sedation & Analgesia â€“ Landmark Trials

## MENDS Trial (2007)
**Journal:** JAMA  
**Design:** Randomized, double-blind, n=106  
**Population:** Mechanically ventilated ICU patients  
**Intervention:** Dexmedetomidine  
**Comparator:** Lorazepam  
**Primary Outcome:** Delirium-free and coma-free days  
**Key Results:** More delirium-free days with dexmedetomidine  
**Key Limitations:** Small sample size  
**Reference:** Pandharipande PP et al., JAMA 2007. PubMed

## SEDCOM Trial (2009)
**Journal:** JAMA  
**Design:** Multicenter RCT, n=375  
**Population:** Mechanically ventilated ICU patients  
**Intervention:** Dexmedetomidine  
**Comparator:** Midazolam  
**Primary Outcome:** Time at target sedation  
**Key Results:** Less delirium and shorter ventilation duration  
**Reference:** Riker RR et al., JAMA 2009. PubMed

## SPICE III Trial (2019)
**Journal:** NEJM  
**Design:** Multicenter RCT, n=4000  
**Population:** Ventilated ICU patients  
**Intervention:** Early dexmedetomidine-based sedation  
**Comparator:** Usual care  
**Primary Outcome:** 90-day mortality  
**Key Results:** No mortality benefit  
**Reference:** SPICE III Investigators, NEJM 2019. PubMed

## NONSEDA Trial (2020)
**Journal:** Intensive Care Medicine  
**Design:** Multicenter RCT, n=700  
**Population:** Mechanically ventilated patients  
**Intervention:** No continuous sedation  
**Comparator:** Light sedation  
**Primary Outcome:** 90-day mortality  
**Key Results:** No significant difference  
**Reference:** Olsen HT et al., ICM 2020. PubMed
